Key Ratios

Valuation

P/E (TTM) --
P/E (FY) --
P/E 5 Fiscal Year High $83.08
P/E 5 Fiscal Year Low $83.08
Price to Revenue (TTM) $3.25
Price to Revenue (MRQ) $3.36
Price to Revenue (FY) $3.28
Price To Cash Flow (TTM) $142.70
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) $58.10
Price to Free Cash Flow (TTM) --
Price to Free Cash Flow (FY) $191.45
Price to Book (MRQ) $2.40
Price to Book (FY) $2.33
Price to Tangible Book (MRQ) $2.79
Price to Tangible Book (FY) $2.69
Price to Tangible Book - Common (MRQ) $3.10
Price to Tangible Book - Common (FY) $3.07

Profitability

Operating Margin (TTM) (%) -5.05
Operating Margin (MRQ) (%) -16.98
Operating Margin (FY) (%) -0.37
Net Profit Margin (TTM) % -4.15
Net Profit Margin (MRQ) (%) -12.41
Net Profit Margin (FY) (%) -0.79
Gross Margin (TTM) (%) 35.15
Gross Margin (MRQ) (%) 29.22
Gross Margin (FY) (%) 37.80

Efficiency

Receivables Turnover (TTM) $8.37
Receivables Turnover (MRQ) $6.90
Receivables Turnover (FY) $7.65
Asset Turnover (TTM) $0.55
Asset Turnover (MRQ) $0.52
Asset Turnover (FY) $0.54
Inventory Turnover (TTM) $2.23
Inventory Turnover (MRQ) $2.62
Inventory Turnover (FY) $2.08

Per Share

Revenue/Share (TTM) $5.04
Revenue/Share (MRQ) $5.04
Revenue/Share (FY) $4.97
EPS Fully Diluted (TTM) $-0.21
EPS Fully Diluted (MRQ) $-0.16
Book Value/Share (MRQ) $7.01
Book Value/Share (FY) $7.24
Cash Flow/Share (TTM) $0.11
Cash Flow/Share (MRQ) $-0.29
Cash Flow/Share (FY) $0.28
Cash (MRQ) $1.23
Cash (FY) $1.46

Growth

5 Year Annual Growth (%) 1.07
5-Year Annual Dividend Growth Rate (%) --
5-Year Annual Revenue Growth Rate (%) 3.29
5 Year EPS Growth (%) --

Financial Strength

Quick Ratio (MRQ) $1.53
Quick Ratio (FY) $1.85
Current Ratio (MRQ) $2.40
LT Debt to Equity (MRQ) (%) $12.14
LT Debt to Equity (MRQ) (%) 12.14
LT Debt to Equity (FY) (%) 12.11
Total Debt to Equity (MRQ) (%) 13.99
Total Debt to Equity (FY) (%) 13.98

Management Effectiveness

Return on Equity (TTM) (%) -3.07
Return on Equity (MRQ) (%) -8.75
Return on Equity (FY) (%) -0.57
Return on Assets (TTM) (%) -2.27
Return on Assets (MRQ) (%) -6.43
Return on Assets (FY) (%) -0.43
Return on Investment (TTM) (%) -2.71
Return on Investment (MRQ) (%) -7.60
Return on Investment (FY) (%) -0.50

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States